How do you pay?

How to pay the least

Cash price

$1,560+ for 30 tablets

Pharmacies pay about this for Vemlidy; you’d pay more.

  1. Ask your pharmacy for Vemlidy’s cash price, and one or two other pharmacies too.
  2. Vemlidy’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Support Path Patient Assistance Program. Or call 1-855-769-7284.

See if you qualify 

No generic is sold yet.

Compare every option

Question
Brand nameVemlidy
Authorized generictenofovir alafenamide
Regular generictenofovir alafenamide
What you’d pay
At least$1,560for 30 tablets; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Vemlidy?
The original
–
–

Brand nameThe maker’s card

Vemlidy Co-pay Savings Program (Gilead Support Path)

Savings card from Gilead Sciences

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a fill

The card takes up to $6,000 a year off your co-pay.

Sign up on vemlidy.com 

Or call 1-855-769-7284.

In the maker’s words

“Determine if you are eligible to pay as low as $0 for your co-pay…”

From the maker’s offer on vemlidy.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Vemlidy itself, from the same company, sold without the brand name, and usually for less. For now Vemlidy is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

VEMLIDY is a hepatitis B virus (HBV) nucleoside analog reverse transcriptase inhibitor and is indicated for the treatment of chronic hepatitis B virus infection in adults and pediatric patients 6 years of age and older and weighing at least 25 kg with compensated liver disease.

Source: the FDA label for Vemlidy (Gilead Sciences, Inc.), July 14, 2025. Full label on DailyMed 

Good to know